title: [Interventional oncology for lung tumors].
abstract: Lung tumors and pulmonary metastases together are the most common cause of cancer-related death in men and the second most frequent in women. Up to now, surgical resection has remained the gold standard in the treatment of pulmonary tumors, being the only treatment option that was potentially curative and offered the possibility of a significant increase in life expectancy after successful therapy. Over the past decade, percutaneous radiofrequency ablation (RFA) has gained worldwide acceptance in the treatment of primary and secondary tumors of the liver with curative intent, so that indications for RFA have been extended to embrace tumors in other organs, e.g. the lung. Since the first case results were described, the number of publications dealing with the treatment of lung tumors using thermal ablative therapies has increased significantly. The aims of the present article are to give a short overview of emerging therapies such as cyberknife surgery and also, especially, to describe the indications for and technique of RFA, to discuss the ideal method of follow-up, and to highlight possible complications of the therapy and the current results of RFA of primary and secondary lung tumors. In addition, the value of combining RFA with other therapy modes (especially chemotherapy and radiation therapy)is briefly treated.
authors.affiliation: Institut für klinische Radiologie, Klinikum Grosshadern der Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, München, Deutschland. ralf-thorsten.hoffmann@med.uni-muenchen.de
authors.forename: R-T
authors.initials: RT
authors.lastname: Hoffmann
authors.forename: T F
authors.initials: TF
authors.lastname: Jakobs
authors.forename: A
authors.initials: A
authors.lastname: Muacevic
authors.forename: C
authors.initials: C
authors.lastname: Trumm
authors.forename: T K
authors.initials: TK
authors.lastname: Helmberger
authors.forename: M F
authors.initials: MF
authors.lastname: Reiser
mesh_terms: D004564:Electrocoagulation / Q000379:methods*; D005471:Fluoroscopy / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D019060:Minimally Invasive Surgical Procedures / Q000379:methods*; D015642:Radiology, Interventional / Q000379:methods*; D016634:Radiosurgery / Q000379:methods*; D015996:Survival Rate; D014057:Tomography, X-Ray Computed / Q000379:methods